The purpose of this study is to compare two different anti-HIV drug combinations, one that contains nelfinavir (NFV) and one that does not. The best dosing schedule for indinavir (IDV) also will be studied.
Patients are stratified by screening plasma viral RNA results (50,000 copies/ml or below vs above 50,000 copies/ml) and randomized to 1 of 2 treatment arms. Group 1 receives IDV 3 times daily plus d4T/3TC twice daily. Group 2 receives IDV/NFV/d4T/3TC twice daily. Patients remain on study medications for 24 weeks and are seen at the clinic once every 4 weeks after entering the study. At each clinic visit, blood samples are taken to evaluate CD4 cell count and plasma HIV RNA levels.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Enrollment
220
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Univ of Alabama School of Med
Montgomery, Alabama, United States
Ocean View Internal Medicine
Long Beach, California, United States
AIDS Healthcare Foundation
Los Angeles, California, United States
Tower ID Med Associates
Los Angeles, California, United States
Oasis Clinic / King Drew Med Ctr
Los Angeles, California, United States
Robert Scott MD
Oakland, California, United States
AIDS Community Research Consortium
Redwood City, California, United States
Saint Francis Mem Hosp / HIV Care Unit
San Francisco, California, United States
Pacific Horizons Med Group
San Francisco, California, United States
Kaiser Foundation Hospital
San Francisco, California, United States
...and 36 more locations